Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Revue Du Rhumatisme (English Ed.)
|
December 11, 1999
Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology
S Perrot, B Bannwarth, P Bertin, et al.
Environmental Science and Pollution Research International
|
November 16, 2013
SimPhy: a simulation game to lessen the impact of phytosanitaries on health and the environment--the case of Merja Zerga in Morocco
H Ayadi, M Le Bars, Ph Le Grusse, et al.
Clinical and Experimental Rheumatology
|
May 21, 2010
Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data
M Dougados, G Wells, N Schmidely, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
B Mazières, N Scmidely, H J Hauselmann, et al.
Neuro-Chirurgie
|
January 1, 1992
[Laser microsurgery of meningioma. An analysis of a consecutive series of 164 cases treated surgically by using different lasers]
M Desgeorges, O Sterkers, A Ducolombier, et al.
Annals of the Rheumatic Diseases
|
December 17, 2008
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data
M Dougados, N Schmidely, M Le Bars, et al.
Annals of the Rheumatic Diseases
|
October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
M C Genovese, M Schiff, M Luggen, et al.
Annals of the Rheumatic Diseases
|
December 17, 2008
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
M Schiff, C Pritchard, J E Huffstutter, et al.
Annals of the Rheumatic Diseases
|
May 13, 2009
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
P G Conaghan, M A D'Agostino, M Le Bars, et al.
Annals of the Rheumatic Diseases
|
May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility
P Conaghan, M A D'Agostino, P Ravaud, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Revue Du Rhumatisme (English Ed.)
|
December 11, 1999
Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology
S Perrot, B Bannwarth, P Bertin, et al.
Environmental Science and Pollution Research International
|
November 16, 2013
SimPhy: a simulation game to lessen the impact of phytosanitaries on health and the environment--the case of Merja Zerga in Morocco
H Ayadi, M Le Bars, Ph Le Grusse, et al.
Clinical and Experimental Rheumatology
|
May 21, 2010
Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data
M Dougados, G Wells, N Schmidely, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
B Mazières, N Scmidely, H J Hauselmann, et al.
Neuro-Chirurgie
|
January 1, 1992
[Laser microsurgery of meningioma. An analysis of a consecutive series of 164 cases treated surgically by using different lasers]
M Desgeorges, O Sterkers, A Ducolombier, et al.
Annals of the Rheumatic Diseases
|
December 17, 2008
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data
M Dougados, N Schmidely, M Le Bars, et al.
Annals of the Rheumatic Diseases
|
October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
M C Genovese, M Schiff, M Luggen, et al.
Annals of the Rheumatic Diseases
|
December 17, 2008
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
M Schiff, C Pritchard, J E Huffstutter, et al.
Annals of the Rheumatic Diseases
|
May 13, 2009
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
P G Conaghan, M A D'Agostino, M Le Bars, et al.
Annals of the Rheumatic Diseases
|
May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility
P Conaghan, M A D'Agostino, P Ravaud, et al.
Page
of 3